Back to Directory
Parathyroid Hormone 1-84
Performance & EnduranceFull-length recombinant PTH for hypoparathyroidism, the only FDA-approved treatment.
Key Benefits
- ✓Controls calcium in hypoparathyroidism
- ✓Reduces calcium supplement needs
- ✓Maintains serum calcium
- ✓Improves quality of life
- ✓Only approved PTH replacement
Dosing Information
Dosage Range
25-100 mcg
Frequency
Once daily
Typical Duration
Ongoing
Detailed Protocol
Administered via subcutaneous injection once daily in the thigh. Dose titrated based on serum calcium levels. Requires close monitoring. Prescription only.
About Parathyroid Hormone 1-84
PTH 1-84 (Natpara) is recombinant full-length human parathyroid hormone consisting of all 84 amino acids. FDA-approved as the only treatment for hypoparathyroidism to control calcium and reduce need for calcium/vitamin D supplements.
Research Notes
FDA-approved in 2015 for hypoparathyroidism. Temporarily withdrawn 2019-2023 due to manufacturing issues, now available again. Only approved treatment option.
Potential Side Effects
- •Hypercalcemia risk
- •Hypocalcemia risk
- •Paresthesias
- •Headache
- •Black box warning for osteosarcoma
- •Requires monitoring
Always consult with a healthcare professional before starting any peptide therapy.